Summary.-110 consecutively diagnosed breast-cancer patients in all stages were included in a study to evaluate a selective surgical and radiotherapeutical treatment. The surgical treatment was total mastectomy and exploration of the axilla, with lymphnode biopsy and peroperative cytological examination. Axillary dissection was done only when this examination showed metastases. No radiotherapy was given to the axilla in patients with lateral cancers in the absence of metastases, or with limited metastasization (no periglandular growth, no growth in apical nodes). In medial and central cancers, radiotherapy was applied to the parasternal and supraclavicular nodes irrespective of axillary involvement. A staging system with a combined clinical and histopathological classification was used and formed the basis for the selective treatment.
Summary.-110 consecutively diagnosed breast-cancer patients in all stages were included in a study to evaluate a selective surgical and radiotherapeutical treatment. The surgical treatment was total mastectomy and exploration of the axilla, with lymphnode biopsy and peroperative cytological examination. Axillary dissection was done only when this examination showed metastases. No radiotherapy was given to the axilla in patients with lateral cancers in the absence of metastases, or with limited metastasization (no periglandular growth, no growth in apical nodes). In medial and central cancers, radiotherapy was applied to the parasternal and supraclavicular nodes irrespective of axillary involvement. A staging system with a combined clinical and histopathological classification was used and formed the basis for the selective treatment.
The corrected 5-year survival for the whole material was 80%, for those without axillary metastasis (Stage I) 950% and for those with axillary metastasis (Stage II) 68%. Six women were alive with known distant metastases. Of 63 patients without identified axillary metastases at the time of surgery, axillay recurrences occurred in only 3 (5 0%). It was concluded that patients without axillary metastases can be reliably selected by the peroperative examination used, and that in this group simple mastectomy results in a high disease-free survival. Early diagnosis and a possible beneficial effect of the actual therapeutic programme might both have contributed to the high overall survival. THE TREATMENT of operable breast carcinoma has in most earlier studies been the same, irrespective of tumour location, size and axillary involvement. Different classification systems, or the absence of tumour classification, have made comparisons between different materials difficult. It has very often been stated that the end result is independent of the type of treatment. However, some studies, though not randomized, have shown superior treatment results (e.g. Gray & Anglem, 1959; Haagensen et al., 1969) . Furthermore, the survival rate has shown a definite tendency to improve decade by decade during this century (Mansfield, 1976 The present study was undertaken to evaluate a differentiated treatment, based primarily on tumour location and axillarynode involvement. Primary emphasis was put on the overall 5-year survival and recurrence rate in this unselected series, and on the possibility of a reliable peroperative assessment of axillary-node involvement as the basis for surgical treatment of the axilla. The definite evaluation of the differentiated treatment programme used in this study needs, of course, the design of a randomized trial. The large number of patients needed to assure relevant differences in survival to be detected (e.g. Graffman & Jung, 1970) and the difficulty in obtaining a standardized handling of patients in a multicentre study did, however, make this analysis of a properly controlled pilot study interesting.
PATIENTS AND METHODS
116 women with primary breast carcinoma were treated at the Departments of Surgery and Oncology, University Hospital, Uppsala, Sweden from August 1972 to October 1973. They represented the total material of newly detected breast carcinoma cases in Uppsala county during this period. Two patients died before any treatment; one from pancreatitis and the other from advanced liver metastases. Four patients did not accept the recommended therapy. Thus, 6 patients in all were excluded from the present study, which included 110 patients.
The mean age was 60-3 ± 14-5 years (range 27-91 at the time of diagnosis; 32 (29%) were under the age of 50 and 35 (32%) were premenopausal.
The diagnostic examination were concentrated in a special out-patient clinic, where all women with breast symptoms were allowed to seek an examination without previous referral, with a waiting time of only a few days. Clinical examination, fineneedle biopsy with cytological examination and mammography, was performed in close cooperation between a few physicians at the first consultation Rimsten et al., 1975) .
The size of the tumours was measured at examination before the treatment, and was also obtained form the pathological specimen.
The mean palpatory size was 2-3 i 1-6 cm and the mean pathological measure 2-2 + 1-3 cm. 67 tumours were located in the lateral part of the breast and 43 in the medial or central part.
The cancers were classified according to the Columbia Clinical Classification (Haagensen, 1971) . 76 of the cancers were classified as After surgical treatment the patients were reclassified according to a Combined Clinical and Histological Classification (Table I) .
Histopathology.-Classification was according to Ackerman & del Regato (1970) a further development of a malignancy grading suggested by Hultborn & Tornberg (1960 (Rimsten et al., 1974; (Kirk et al., 1971 Recurrences.-Local and axillary recurrences were treated with excision or radiotherapy, and in some cases local recurrences with anti-oestrogens. Distant metastases were primarily treated with hormone therapy. In the case of treatment failure, cytostatic treatment was used.
Follow-up.-Patients were followed up at the Department of Oncology at regular intervals from 4 years 9 months to 5 years 10 months (only 32 patients were followed from 4 years 9 months to 4 years 11 months). Primarily, X-irradiation of the lungs and skeleton was performed and a laboratory survey was done. In advanced cases, and in patients with symptoms, skeleton and liver scintigrams were also made.
Recurrences were noted as local, axillary or distant. Local recurrences were those located within the treatment area (chest wall, parasternal and supraclavicular). Distant metastases were skeletal, visceral, cutaneous and subcutaneous, outside the treatment area.
The causes of death were recorded and the survival rate calculated, both crude and corrected, for the actual number of intercurrent deaths.
RESULTS

Survival
In the total material, 81/110 women to a crude survival of 74% (Table II) .
When corrected for death due to intercurrent diseases, survival was 80%. Twenty one patients died from distant metastases (including 4 initially in Stage IV). Eight women died from other causes, without signs of remaining cancer. Six patients were alive with known distant metastases (Table III) . Survival related to the two systems of classification is shown in Tables II and  IV . According to the combined clinical and histopathological classification (Table  II) the crude 5-year survival was 87% (55/63) in Stage I. However, in only 3/8 deceased women was death due to breast cancer; giving a corrected survival of 95%.
Both classification systems showed a fairly good separation into stages with significantly different prognosis. The combined classification also dichotomized Stage II into those without (Ila) and those with (Ilb) perinodal tumour growth or apical-node involvement; the crude survival being 82% (9/11) and 50% (10/20), respectively. Five of the 8 women in Stage III and all 4 in Stage IV were dead at follow-up (Table II) (1) 3 (2) 3 (1) 2 (1) 5 (5) 3 (3) 13 (10) in 7 cases. This gives a total frequency of 10% (11/110) (Table II) local recurrences within 5 years. Five of these patients died during the observation period.
DISCUSSION
The present study was designed to evaluate the results of a programme for selective surgical and radiotherapeutic treatment, based on the location of the primary tumour and on the axillary-node status. Simple mastectomy and modified radical mastectomy as used in this series is at present the dominating surgical treatment for breast carcinoma in Great Britain and also in Sweden (Adami et al., 1976; Breast Cancer Symposium, 1969) .
In operable breast cancer (Stages I and II) simple mastectomy has one major disadvantage: the lack of information about the state of the axillary nodes, which is accepted as the main determinant In patients without axillary metastases, on the other hand, axillary dissection can be considered as an unnecessary mutilating procedure, and the excision and irradiation of uninvolved lymph nodes superfluous. It does also introduce the risk of postoperative arm swelling and restriction of arm movements. In addition, it has been suggested that the axillary nodes participate in the immunological defence against cancer spread (Crile, 1967; Fisher, 1971) and that postoperative irradiation may be harmful by suppressing the host response (Stjernsward, 1974) . These data were considered as contradicting the routine use of exaeresis or irradiation of the axilla if node metastases could be excluded.
It is well established that the clinical assessment of axillary-node involvement is highly uncertain, with at least 30 % false-positive findings and about the same frequency of false-negatives (Wallace & Champion, 1972; Silverberg, 1975; Schottenfeld et al., 1976; Freund et al., 1977) . Selective treatment based on axillarynode status does, therefore, presuppose that axillary metastases can be diagnosed at the time of surgery. It was a major experience from this study, as from a previous preliminary report (3/63) after 5 years in those with negative biopsies (Stage I) and therefore without axillary dissection or irradiation, seems encouraging. This is lower than that of the 8% (6/75) reported by Forrest et al. (1974) after pectoral-node biopsy, with a shorter observation period than in this study.
Much of the controversy about breastcancer treatment probably has its origin in the lack of results based on unselected patient materials. The relative inaccuracy of clinical staging has further contributed to the persistent disagreement about the optimal local primary treatment in breast cancer. Another factor is the lack of consequent correction for deaths due to intercurrent diseases. The possible beneficial effect on survival by active efforts to obtain an early diagnosis and improved treatment can best be evaluated within the frame of randomized trials. Our present results, based on a restricted number of patients, thus have to be considered with some caution, but they can allow a comparison with other materials of well-classified tumours. The overall 5-year survival in patients with operable breast cancer, treated by radical mastectomy, has varied in different reports between 49% (Finney et al., 1947) and 74-5% (Gray & Anglem, 1959) . Most series are selected, however, in different ways, and survival figures based on total materials are difficult to find. A 5-year survival of 46-5% was found in total Swedish material (Nohrman, 1949 ) and a figure of 5500 was later reported by Kaae & Johansen (1968) . A recent study from Sweden showed a corrected 5-year survival of 70.7% (Johnsen, 1975) . The corrected survival of 80% in our study seems anyhow to be higher than that in most other materials. In addition, only 6 patients are living with known distant metastases.
Principally, this favourable survival can be due to the type of treatment used, and to the early diagnosis which has been claimed to account for an improvedsurvival (Anglem & Leber, 1971; Johnsen, 1975) . Early diagnosis has probably contributed much to the favourable results in this study. This is indicated by the relatively small mean tumour size and by the high frequency of patients with negative axillary nodes. The present figure of 61 % in this unselected patient material is, in fact, in close accordance with that of 63% by Strax (1976) in women at annual screening.
In women without axillary metastases, the 5-year survival has been 70 ± 10%
in most studies (Mansfield, 1976) . A survival rate 80°/, has been reported after both radical mastectomy (Haagensen et al., 1969; Payne et al., 1970) and modified radical mastectomy (Madden et al., 1972 significantly influenced, not only by the existence of axillary metastases, but also by the number of nodes involved (Haagensen, 1971; Silverberg, 1975) and by their location in the axilla (Urban, 1960) where tumour growth in the apical nodes indicates an especially bad prognosis. A detailed assessment of these factors might, however, be considered inappropriate for routine use, whereas the recognition of perinodal tumour growth is easily done at a conventional histopathological examination. The obvious significance of this factor on the prognosis has been shown earlier (e.g. Johnsen, 1975) . It is also evident from this study and is a point of real interest. The significance of perinodal growth and the uncertainty of the clinical assessment of the axillary nodes indicate the value of the combined clinical and histopathological classification as suggested in this study. This classification has a great prognostic significance and can be used to individualize the treatment. It can also contribute to a more meaningful comparison between different studies.
